- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00670644
Self-Care for Lymphedema in Patients With Breast Cancer
Breast Cancer Treatment Related Lymphedema Self Care Practices
RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment.
PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
Primary
- To systematically identify and describe the barriers to completing recommended at home self-care of lymphedema in patients with breast cancer.
- To identify patient recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others.
- To identify the current at home self-care practices of breast cancer survivors with treatment treated lymphedema.
Secondary
- To examine the relationship between at home self-care activities and symptoms in breast cancer survivors with lymphedema.
- To examine the relationship between at home self-care activities and quality of life in breast cancer survivors with lymphedema.
- To identify patient-perceived benefits to at home self-care.
OUTLINE: Patients complete questionnaires about their breast cancer diagnosis and treatment history, lymphedema history and problems, and years of education and income. Patients also complete surveys about home self-care practices for lymphedema and any benefits, burdens, or barriers of at home care.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Tennessee
-
Nashville, Tennessee, États-Unis, 37232-6838
- Vanderbilt-Ingram Cancer Center
-
Nashville, Tennessee, États-Unis, 37064
- Vanderbilt-Ingram Cancer Center - Cool Springs
-
Nashville, Tennessee, États-Unis, 37064
- Vanderbilt-Ingram Cancer Center at Franklin
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
DISEASE CHARACTERISTICS:
- History of breast cancer
- Lymphedema in one or both arms that occurred during or after breast cancer treatment
Must have received prior lymphedema treatment by a healthcare professional
- Patients with self-reported arm swelling subsequent to breast cancer treatment that has not been treated by a healthcare professional are not eligible
- Hormone receptor status not specified
PATIENT CHARACTERISTICS:
- Menopausal status not specified
- English speaking
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Identification and description of barriers to completing recommended at home self-care of lymphedema
Délai: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
|
Identification of patients recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others
Délai: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
|
Identification of current at home self-care practices for lymphedema
Délai: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Relationship between at home self-care activities, symptoms, and quality of life in breast cancer survivors with lymphedema
Délai: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
|
Identification of patient-perceived benefits to at home self-care
Délai: one time only for approximately 15 minutes
|
one time only for approximately 15 minutes
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: Shiela H. Ridner, MSN, PhD, RN, Vanderbilt-Ingram Cancer Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CDR0000587714
- P30CA068485 (Subvention/contrat des NIH des États-Unis)
- VU-VICC-SUPP-0628
- VU-VICC-060480
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .